Angharad Beckett on the recent Confidential Inquiry into Premature Deaths of People with Learning Difficulties (CIPOLD)
Mark Monaghan on a half-day research event held in April this year to explore emerging issues around cannabis.
Recent reports that the NHS has achieved a 'ground breaking 50% increase in deceased organ donors' have met with a mixed response amongst commentators, who have queries the way the statistics have been presented and asked if the situation is perhaps less positive than it appears. Ana Manzano-Santaella examines the evidence.
It is now well recognised that patients have lots of experience and insight into the nature of their illnesses and impairments and that their perspectives on the kinds of research, diagnostic and treatment practices that might improve their situation and that of their fellow patients need to be valued and taken into account by scientists, clinicians and managers.
Responsible Innovation is on the policy agenda. But STS scholars worry that promoting public engagements is being translated into promoting public acceptability, and that collective responsibilities have become matters of risk management by individual scientists. How can STS address this impasse? We need to continue to work alongside scientists and engineers, to engage in dialogue and discussion, but are WE responsible innovation for too?
To understand new technologies like human enhancers we need to engage with social practice and matters of care…
Thank you to everyone who came along to our inaugural seminar last night. We had a lively discussion on human enhancement technologies and the importance of understanding social practice and matters of care when analysing, predicting or otherwise debating their significance.